Viewing nowAnpogrel SR Tablet (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 201903501 · Approved 2019.05.28 · Insurance code 640903840
Improvement of ischemic symptoms associated with chronic arterial occlusive disease (ulcers, pain, etc.)
This medication is used to improve ischemic symptoms such as ulcers, pain, and coldness caused by chronic arterial occlusive disease, Buerger's disease, obliterative arteriosclerosis, and diabetic peripheral vascular disease.
Adults: 300 mg of Sarpogrelate Hydrochloride extended-release tablet should be taken orally once daily after meals. Do not chew or crush the tablets; take them whole.
This medication should not be used in patients with bleeding as it may exacerbate hemorrhage. Women who are pregnant or may become pregnant should also avoid using this medication. Patients who are menstruating or have a tendency to bleed should use this medication cautiously, as the risk of bleeding may increase when taken with anticoagulants or platelet aggregation inhibitors. Patients with severely impaired kidney function and the elderly should use this medication carefully. This medication can cause various side effects such as urticaria, dyspepsia, diarrhea, headache, cough, and rarely may result in serious adverse reactions such as severe bleeding or liver dysfunction. Therefore, if any abnormal symptoms arise, immediate consultation with healthcare providers is necessary. Regular blood tests are recommended while taking this medication. Always inform healthcare providers before use if taking anticoagulants or platelet aggregation inhibitors, as the risk of bleeding may increase. It is safest for pregnant or breastfeeding women not to use this medication, and if unavoidable, it is advisable to avoid breastfeeding. Safety in children has not been confirmed, and there is limited experience in use. Lastly, this medication should be stored out of reach of children, and it is important not to transfer it to another container to maintain quality.
Urticaria, bleeding (gastrointestinal bleeding, cerebral hemorrhage, subcutaneous bleeding, etc.), agranulocytosis, anemia, thrombocytopenia, leukopenia, acute hepatitis, liver impairment, jaundice, erythema, rash, flushing, papules, itching, dyspnea.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air or moisture from entering, and it is best to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.
White oblong film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.